FDA inspection
Taiwan Shuenn-An Biotechnology Pharmaceutical Co., Ltd: FDA inspection ending Jun 16, 2023
FDA inspection 1210838 · Voluntary Action Indicated (VAI) · Gao Xiong Shi
Key facts
| Inspection ID | 1210838 |
|---|---|
| Firm | Taiwan Shuenn-An Biotechnology Pharmaceutical Co., Ltd |
| FEI number | 3008038248 |
| Address | 876 Fenglin 2nd Rd., Daliao Dist. |
| City | Gao Xiong Shi |
| Country | Taiwan |
| Fiscal year | 2023 |
| Inspection end date | Jun 16, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data